Unlock instant, AI-driven research and patent intelligence for your innovation.

Separable microneedle array capable of delivering medicine and performing in-vivo in-situ marking and preparation method of separable microneedle array

A microneedle array and in situ labeling technology, which is applied to preparations, microneedles, and pharmaceutical formulations for in vivo experiments, can solve problems such as inability to use Internet information records, inconvenient preservation of paper records, and incompatibility of information. , to achieve the effect of good information marker storage function, high clinical transformation potential, and low pain degree

Pending Publication Date: 2022-05-27
XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] For patients who need multiple doses of administration (repeated administration) or people who are vaccinated, clinical medical staff need to record the number of administrations, but different medical units may not communicate with each other, and Internet information records, paper records, etc. may not be available in poor areas. Quality version records are not easy to save and easy to lose

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Separable microneedle array capable of delivering medicine and performing in-vivo in-situ marking and preparation method of separable microneedle array
  • Separable microneedle array capable of delivering medicine and performing in-vivo in-situ marking and preparation method of separable microneedle array
  • Separable microneedle array capable of delivering medicine and performing in-vivo in-situ marking and preparation method of separable microneedle array

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1: A drug-deliverable and in-situ labelled separable microneedle array and its preparation method, loaded with drugs and fluorescent dyes, and based on carboxymethyl cellulose (CMC) and sodium alginate (ALG) Microneedle arrays with thicker tips and thinner bottoms prepared from aqueous solutions, S1: The original microneedle models with thicker tips and thinner bottoms were designed with SOLIDWORKS 2020 software, and were constructed using polydimethylsiloxane for the preparation of microneedles. Needle mold; the height of the microneedles in the design of the microneedle model in S1 is 300-2000 microns, and the overall shape of the microneedles is thicker at the tip and thinner at the bottom, and the number of microneedles in each array is 1-100; S2: configure the dye solution, add the dye solution into the PDMS mold, and put it into an oven for drying after centrifugation; dyes used in S2 include but are not limited to fluorescein isothiocyanate (FITC) or cryst...

Embodiment 2

[0039]Example 2: A drug-deliverable and in-situ labelled separable microneedle array and its preparation method, loaded with drugs and fluorescent dyes, and based on carboxymethyl cellulose (CMC) and sodium alginate (ALG) Microneedle arrays with thicker tips and thinner bottoms prepared from aqueous solutions, S1: The original microneedle models with thicker tips and thinner bottoms were designed with SOLIDWORKS 2020 software, and were constructed using polydimethylsiloxane for the preparation of microneedles. Needle mold; the height of the microneedles in the design of the microneedle model in S1 is 300-2000 microns, and the overall shape of the microneedles is thicker at the tip and thinner at the bottom, and the number of microneedles in each array is 1-100; S2: configure the dye solution, add the dye solution into the PDMS mold, and put it into an oven for drying after centrifugation; dyes used in S2 include but are not limited to fluorescein isothiocyanate (FITC) or crysta...

Embodiment 3

[0041] Example 3: A drug-deliverable and in-situ labelled separable microneedle array and its preparation method, loaded with drugs and fluorescent dyes, and based on carboxymethyl cellulose (CMC) and sodium alginate (ALG) Microneedle arrays with thicker tips and thinner bottoms prepared from aqueous solutions, S1: The original microneedle models with thicker tips and thinner bottoms were designed with SOLIDWORKS 2020 software, and were constructed using polydimethylsiloxane for the preparation of microneedles. Needle mold; the height of the microneedles in the design of the microneedle model in S1 is 300-2000 microns, and the overall shape of the microneedles is thicker at the tip and thinner at the bottom, and the number of microneedles in each array is 1-100; S2: configure the dye solution, add the dye solution into the PDMS mold, and put it into an oven for drying after centrifugation; dyes used in S2 include but are not limited to fluorescein isothiocyanate (FITC) or cryst...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
heightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a separable microneedle array capable of delivering drugs and labeling in vivo and in situ and a preparation method of the separable microneedle array in the field of preparation of microneedles capable of labeling in vivo and in situ and relates to a microneedle array which is loaded with drugs and fluorescent dyes, is prepared on the basis of a carboxymethyl cellulose (CMC) and sodium alginate (ALG) aqueous solution and has a relatively thick tip end and a relatively thin bottom end. The separable microneedle array with the in-vivo in-situ marking function for drug delivery provided by the invention has effective transdermal drug delivery capacity, information marking and storing functions and good biocompatibility; any number and pattern can be obtained by permutation and combination of the microneedle array, visual information marking is performed on the skin of a treated subject, and paperless recording is realized; meanwhile, in the application of treatment or prevention of administration, the wound on human skin is small, the pain degree is low, the acceptability of a subject to the microneedle administration mode is high, and the clinical transformation potential is high.

Description

technical field [0001] The invention relates to the technical field of preparation of microneedles that can be labeled in situ in vivo, in particular to a separable microneedle array that can be delivered and labeled in situ in vivo and a preparation method thereof. Background technique [0002] At present, the common methods of administration include oral administration and injection administration. When oral administration of drugs is performed, the first-pass elimination of the drug in the liver will greatly reduce the bioavailability of the drug. Injection administration is invasive and accompanied by pain. Children and some patients may be Needle panic, even needle dizziness. [0003] For patients who need multi-dose administration (repeated administration) or people who are vaccinated, clinical medical staff need to record the number of doses, but information may not be communicated between different medical units, and poor areas cannot use Internet information records...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K47/38A61K47/36A61K47/34A61K49/00A61M37/00
CPCA61K9/0021A61K47/38A61K47/36A61K47/34A61K49/0021A61M37/0015A61M2037/0023A61M2037/0053
Inventor 王琳王征陈伟范慧玲许仁珪李琪琳
Owner XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV